COMMUNIQUÉS West-GlobeNewswire
-
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026 -
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
28/04/2026 -
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026 -
Clariane announces the success of its offering of €230 million of additional senior notes
28/04/2026 -
Clariane annonce le succès de son offre de 230 millions d’euros d’obligations senior additionnelles
28/04/2026 -
Axe Compute to Present at the Market Movers Investor Summit and the D. Boral Capital 2026 Global Conference
28/04/2026 -
NBPure Launches Exclusive MagO7 60-Count at Walmart, Expanding Access to Its Best-Selling Gut Cleanse
28/04/2026 -
Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026
28/04/2026 -
The Aesthetic Show Celebrates 19 Years of Innovation, Education, and Excellence in Aesthetic Medicine — Announces Expanded 2026 Event in Las Vegas, June 25 - 28
28/04/2026 -
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
28/04/2026 -
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026
28/04/2026 -
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
28/04/2026 -
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
28/04/2026 -
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
28/04/2026 -
Aeroflow Health Applauds Georgia Medicaid’s New Telehealth Lactation Coverage
28/04/2026 -
Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation
28/04/2026 -
Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer
28/04/2026 -
Ritedose Reaches “1,000 Hours of Purpose”
28/04/2026 -
Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million
28/04/2026
Pages